rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-4-25
|
pubmed:abstractText |
Ceruloplasmin (CP), an important serum antioxidant, was previously found to reduce the incidence of ventricular fibrillation (VF) induced by ischemia and reperfusion in isolated rat hearts. The present study investigated whether CP sterilized by gamma-irradiation maintains its antiarrhythmic capacity and in vitro antioxidant properties.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0955-3002
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
309-17
|
pubmed:meshHeading |
pubmed-meshheading:17457756-Animals,
pubmed-meshheading:17457756-Anti-Arrhythmia Agents,
pubmed-meshheading:17457756-Antioxidants,
pubmed-meshheading:17457756-Ceruloplasmin,
pubmed-meshheading:17457756-Dose-Response Relationship, Radiation,
pubmed-meshheading:17457756-Gamma Rays,
pubmed-meshheading:17457756-Heart,
pubmed-meshheading:17457756-Heart Rate,
pubmed-meshheading:17457756-Myocardial Reperfusion Injury,
pubmed-meshheading:17457756-Rats,
pubmed-meshheading:17457756-Tyrosine,
pubmed-meshheading:17457756-Ventricular Fibrillation
|
pubmed:year |
2007
|
pubmed:articleTitle |
Gamma-irradiated ceruloplasmin affords antifibrillatory protection against ischemia/reperfusion damage in the isolated rat heart.
|
pubmed:affiliation |
Department of Chemistry and Biochemistry, Université du Québec à Montréal, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|